- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT06777368
REdo tranScatheter aortaklapudskiftning for transkateter aortaklapfejl (RESTORE)
The purpose of this study is to generate clinical evidence on valve safety and performance in subjects treated by redo Transcatheter Aortic Valve Replacement (TAVR).
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Primary Objectives:
- To determine the acute and long-term outcomes of redo TAVR for the treatment of BVF affecting TAVs
- To determine the factors which are associated with the acute and long-term outcomes of redo TAVR
Undersøgelsestype
Tilmelding (Anslået)
Kontakter og lokationer
Studiekontakt
- Navn: RESTORE Study Clinical Team
- Telefonnummer: 763 514 4000
- E-mail: RS.RESTORESTUDY@medtronic.com
Studiesteder
-
-
Alabama
-
Birmingham, Alabama, Forenede Stater, 35233
- Rekruttering
- University of Alabama at Birmingham
-
Ledende efterforsker:
- Mustafa Ahmed, MD
-
Kontakt:
- Marissa Waite
-
-
Arizona
-
Phoenix, Arizona, Forenede Stater, 85016
- Rekruttering
- Abrazo Arizona Heart Hospital
-
Ledende efterforsker:
- Timothy Byrne, MD
-
Ledende efterforsker:
- Merick Kirshner, MD
-
Kontakt:
- Jessica Byrne
-
Tucson, Arizona, Forenede Stater, 85712
- Trukket tilbage
- Tucson Medical Center
-
-
California
-
Los Angeles, California, Forenede Stater, 90027
- Rekruttering
- Kaiser Permanente Los Angeles Medical Center
-
Ledende efterforsker:
- Somjot Brar, MD
-
Kontakt:
- Jaclyn Cordova
-
Sacramento, California, Forenede Stater, 95816
- Rekruttering
- Sutter Heatlh
-
Ledende efterforsker:
- Pei-Hsiu Huang, MD
-
Kontakt:
- Jessica McCall
-
Sacramento, California, Forenede Stater, 95825
- Rekruttering
- Kaiser Permanente Northern California
-
Kontakt:
- Ann Rose Downing
-
Ledende efterforsker:
- Femi Philip, MD
-
Stanford, California, Forenede Stater, 94305
- Rekruttering
- Stanford Hospital & Clinics
-
Ledende efterforsker:
- William Fearon, MD
-
Kontakt:
- Ayesha Zaina
-
Kontakt:
- Anushka Marathe
-
Thousand Oaks, California, Forenede Stater, 91360
- Rekruttering
- Los Robles Regional Medical Center
-
Ledende efterforsker:
- Saibal Kar, MD
-
Kontakt:
- Mane Arabyan
-
Ledende efterforsker:
- Greg Fontana, MD
-
-
Colorado
-
Loveland, Colorado, Forenede Stater, 80538
- Rekruttering
- Medical Center of the Rockies
-
Ledende efterforsker:
- Justin Strote, MD
-
Kontakt:
- Darcee Robeson
-
-
Connecticut
-
Hartford, Connecticut, Forenede Stater, 06106
- Rekruttering
- Hartford Hospital
-
Ledende efterforsker:
- Robert Hagberg, MD
-
Kontakt:
- Jadwiga Jerman
-
Ledende efterforsker:
- Sarfaraz Memon, MD
-
New Haven, Connecticut, Forenede Stater, 05610
- Rekruttering
- Yale New Haven Hospital
-
Ledende efterforsker:
- John Forrest, MD
-
Kontakt:
- Scott Ardito
-
-
District of Columbia
-
Washington D.C., District of Columbia, Forenede Stater, 20010
- Rekruttering
- MedStar Washington Medical Center
-
Ledende efterforsker:
- Ron Waksman, MD
-
Kontakt:
- Erin Collins
-
-
Florida
-
Clearwater, Florida, Forenede Stater, 33756
- Rekruttering
- Morton Plant Hospital
-
Ledende efterforsker:
- Joshua Rovin, MD
-
Kontakt:
- Sue Fisher
-
Ledende efterforsker:
- Jayendrakumar Patel, MD
-
Fort Myers, Florida, Forenede Stater, 33908
- Rekruttering
- HealthPark Medical Center, Lee Memorial Health
-
Ledende efterforsker:
- David Cervantes, MD
-
Kontakt:
- Michelle Deckard
-
Orlando, Florida, Forenede Stater, 32806
- Rekruttering
- Orlando Health/Orlando Regional Medical Center
-
Kontakt:
- George Ngo
-
Ledende efterforsker:
- Joel Garcia-Fernandez, MD
-
Tampa, Florida, Forenede Stater, 33606
- Rekruttering
- Tampa General/USF
-
Ledende efterforsker:
- Hiram Bezerra, MD
-
Kontakt:
- Mia Eifrid
-
-
Indiana
-
Fort Wayne, Indiana, Forenede Stater, 46845
- Rekruttering
- Parkview Health
-
Ledende efterforsker:
- Roy Robertson, MD
-
Kontakt:
- Tressa Brunner
-
Indianapolis, Indiana, Forenede Stater, 46290
- Rekruttering
- Saint Vincent Heart Center of Indiana
-
Ledende efterforsker:
- Ezequiel Munoz, MD
-
Kontakt:
- Cari Fekete
-
-
Iowa
-
Des Moines, Iowa, Forenede Stater, 50314
- Rekruttering
- MercyOne Iowa Heart Center
-
Ledende efterforsker:
- David McAllister, MD
-
Kontakt:
- Kendra Tuttle
-
Iowa City, Iowa, Forenede Stater, 52242
- Rekruttering
- University of Iowa Hospitals and Clinics
-
Kontakt:
- Amy Black
-
Kontakt:
- Amy Olinger
-
Ledende efterforsker:
- Philip Horwitz, MD
-
-
Kansas
-
Kansas City, Kansas, Forenede Stater, 66103
- Rekruttering
- The University of Kansas
-
Kontakt:
- Amy Gorsuch
-
Ledende efterforsker:
- George (Trip) Zorn, MD
-
Wichita, Kansas, Forenede Stater, 67214
- Rekruttering
- Ascension Via Christi St. Francis
-
Ledende efterforsker:
- Bassem Chehab, MD
-
Ledende efterforsker:
- Brett Grizzell, MD
-
Kontakt:
- Meredith Thunberg
-
-
Maine
-
Portland, Maine, Forenede Stater, 04102
- Rekruttering
- Maine Medical Center
-
Kontakt:
- Joanne Burgess
-
Ledende efterforsker:
- David Butzel, MD
-
-
Maryland
-
Baltimore, Maryland, Forenede Stater, 21287
- Rekruttering
- The Johns Hopkins Hospital
-
Ledende efterforsker:
- Rani Hasan, MD
-
Kontakt:
- Michele Fisher
-
Baltimore, Maryland, Forenede Stater, 21218
- Rekruttering
- Medstar Union Memorial Hospital
-
Ledende efterforsker:
- John Wang, MD
-
Kontakt:
- Keith Moyer
-
-
Massachusetts
-
Boston, Massachusetts, Forenede Stater, 02114
- Rekruttering
- Massachusetts General Hospital
-
Ledende efterforsker:
- Rahul Sakhuja, MD
-
Kontakt:
- Joanna Mandinova
-
Boston, Massachusetts, Forenede Stater, 02135
- Rekruttering
- Brigham and Women's Hospital
-
Kontakt:
- Sinead Coyle
-
Ledende efterforsker:
- Piotr Sobieszczyk, MD
-
-
Michigan
-
Ann Arbor, Michigan, Forenede Stater, 48109
- Rekruttering
- University of Michigan Health
-
Ledende efterforsker:
- Stanley Chetcuti, MD
-
Kontakt:
- Jessica Frizzell
-
Ledende efterforsker:
- Shininchi Fukuhara, MD
-
Detroit, Michigan, Forenede Stater, 48202
- Rekruttering
- Henry Ford Hospital
-
Ledende efterforsker:
- Pedro Engel Gonzalez, MD
-
Kontakt:
- Emily Ward
-
Grand Rapids, Michigan, Forenede Stater, 49503
- Rekruttering
- Corewell Health (Spectrum)
-
Ledende efterforsker:
- William Merhi, MD
-
Ledende efterforsker:
- Stephane Leung, MD
-
Kontakt:
- Elizabeth Helm
-
-
Minnesota
-
Minneapolis, Minnesota, Forenede Stater, 55407
- Rekruttering
- Abbott Northwestern/Minneapolis Heart
-
Ledende efterforsker:
- Paul Sorajja, MD
-
Ledende efterforsker:
- Vinayak Bapat, MD
-
Kontakt:
- Alexa Hunsinger
-
Rochester, Minnesota, Forenede Stater, 55905
- Rekruttering
- Mayo Clinic
-
Ledende efterforsker:
- Mohamad Alkhouli, MD
-
Kontakt:
- Tricia Conley
-
Saint Cloud, Minnesota, Forenede Stater, 56303
- Rekruttering
- CentraCare Heart and Vascular Center
-
Ledende efterforsker:
- Thom Dahle, MD
-
Kontakt:
- Jennifer Humbert
-
-
Missouri
-
Kansas City, Missouri, Forenede Stater, 64111
- Rekruttering
- St. Luke's Hospital of Kansas City
-
Ledende efterforsker:
- Chetan Huded, MD
-
Kontakt:
- Peggy Owen
-
-
Montana
-
Missoula, Montana, Forenede Stater, 59802
- Rekruttering
- Providence Saint Patrick Hospital
-
Ledende efterforsker:
- Michael Reed, MD
-
Kontakt:
- Tara Westlie
-
Ledende efterforsker:
- Travis Abicht, MD
-
-
New Hampshire
-
Lebanon, New Hampshire, Forenede Stater, 03756
- Rekruttering
- Dartmouth-Hitchcock Medical Center
-
Ledende efterforsker:
- Michael Young, MD
-
Kontakt:
- Brian Aldrich
-
Manchester, New Hampshire, Forenede Stater, 03102
- Rekruttering
- Catholic Medical Center
-
Kontakt:
- Jennifer Driscoll
-
Ledende efterforsker:
- Fahad Gilani, MD
-
-
New Jersey
-
Neptune City, New Jersey, Forenede Stater, 07753
- Rekruttering
- Jersey Shore University Medical Center
-
Ledende efterforsker:
- Matthew Saybolt, MD
-
Kontakt:
- Ann Marie DeToro
-
Paramus, New Jersey, Forenede Stater, 07652
- Rekruttering
- The Valley Hospital
-
Ledende efterforsker:
- Rajiv Tayal, MD
-
Kontakt:
- Kimberly Michel
-
-
New York
-
Buffalo, New York, Forenede Stater, 14203
- Rekruttering
- Buffalo General Medical Center
-
Ledende efterforsker:
- Vijay Iyer, MD
-
Kontakt:
- Lindsay Moshides
-
Manhasset, New York, Forenede Stater, 11030
- Rekruttering
- Northwell Health
-
Ledende efterforsker:
- Bruce Rutkin, MD
-
Kontakt:
- Kristine McGowan
-
New York, New York, Forenede Stater, 10029
- Rekruttering
- Mount Sinai Hospital
-
Ledende efterforsker:
- Samin Sharma, MD
-
Kontakt:
- Mercedes Morales Castro
-
New York, New York, Forenede Stater, 10016
- Rekruttering
- NYU Langone Medical Center
-
Kontakt:
- Patricia Kozikowski
-
Ledende efterforsker:
- Mathew Williams, MD
-
Roslyn, New York, Forenede Stater, 11576
- Rekruttering
- Saint Francis Hospital
-
Ledende efterforsker:
- George Petrossian, MD
-
Ledende efterforsker:
- Newell Robinson, MD
-
Kontakt:
- Joan Jennings
-
The Bronx, New York, Forenede Stater, 10467
- Rekruttering
- Montefiore Medical Center
-
Ledende efterforsker:
- Mohamed Azeem Latib, MD
-
Kontakt:
- Tammy Rodriguez Guzman
-
-
North Carolina
-
Winston-Salem, North Carolina, Forenede Stater, 27157
- Rekruttering
- Astrium Health Wake Forest Baptist Medical Center
-
Kontakt:
- Hollie B Davis
-
Ledende efterforsker:
- Peter Belford, MD
-
Ledende efterforsker:
- Edward Kincaid, MD
-
-
Ohio
-
Cincinnati, Ohio, Forenede Stater, 45219
- Rekruttering
- The Christ Hospital
-
Ledende efterforsker:
- Puvi Seshiah, MD
-
Kontakt:
- Amanda Sears
-
Cleveland, Ohio, Forenede Stater, 44106
- Rekruttering
- University Hospitals of Cleveland Medical Center
-
Ledende efterforsker:
- Guilherme Attizzani, MD
-
Kontakt:
- Nisreen Zueiter
-
Ledende efterforsker:
- Cristian Baeza, MD
-
Columbus, Ohio, Forenede Stater, 43214
- Rekruttering
- OhioHealth Riverside Methodist Hospital
-
Kontakt:
- Kailee Brooks
-
Ledende efterforsker:
- Laura Flannery, MD
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Forenede Stater, 73120
- Rekruttering
- Oklahoma Heart Hospital
-
Ledende efterforsker:
- Mohammad Ghani, MD
-
Kontakt:
- Debbie Schommer
-
-
Oregon
-
Portland, Oregon, Forenede Stater, 97225
- Rekruttering
- Providence Saint Vincent Medical Center
-
Ledende efterforsker:
- Brandon Jones, MD
-
Kontakt:
- Angela Redd
-
-
Pennsylvania
-
Allentown, Pennsylvania, Forenede Stater, 18103
- Rekruttering
- Lehigh Valley Hospital
-
Kontakt:
- Traci Eichelberger
-
Ledende efterforsker:
- Dzanan Ramic, MD
-
Mechanicsburg, Pennsylvania, Forenede Stater, 17050
- Rekruttering
- UPMC Pinnacle
-
Kontakt:
- Olivia Vehabovic
-
Ledende efterforsker:
- Hemal Gada
-
Pittsburgh, Pennsylvania, Forenede Stater, 15212
- Rekruttering
- Allegheny General Hospital
-
Kontakt:
- Tracy Spirk
-
Ledende efterforsker:
- Ramzi Khalil, MD
-
Pittsburgh, Pennsylvania, Forenede Stater, 15213
- Rekruttering
- UPMC Presbyterian
-
Ledende efterforsker:
- Ibrahim Sultan, MD
-
Kontakt:
- Stephanie Shearer
-
Ledende efterforsker:
- Dustin Kliner, MD
-
Wynnewood, Pennsylvania, Forenede Stater, 19096
- Rekruttering
- Lankenau Medical Center
-
Ledende efterforsker:
- Basel Ramlawi, MD
-
Kontakt:
- Eunita Chandardat
-
-
Tennessee
-
Nashville, Tennessee, Forenede Stater, 37203
- Rekruttering
- TriStar Centennial Medical Center
-
Ledende efterforsker:
- Andrew Goodman, MD
-
Kontakt:
- Anna Grace Monroe
-
Nashville, Tennessee, Forenede Stater, 37205
- Rekruttering
- St. Thomas West Hospital
-
Kontakt:
- Gabriel Bryant
-
Ledende efterforsker:
- Michael Andrew Morse, MD
-
-
Texas
-
Austin, Texas, Forenede Stater, 78705
- Rekruttering
- Ascension Seton Medical Center Austin
-
Ledende efterforsker:
- Mark Pirwitz, MD
-
Kontakt:
- Madeline Gleason
-
Austin, Texas, Forenede Stater, 78705
- Rekruttering
- Heart Hospital of Austin
-
Kontakt:
- Alana Rice
-
Ledende efterforsker:
- Frank Zidar, MD
-
Houston, Texas, Forenede Stater, 77030
- Rekruttering
- Houston Methodist Hospital
-
Ledende efterforsker:
- Sachin Goel, MD
-
Kontakt:
- Tia McGaughy
-
Houston, Texas, Forenede Stater, 77479
- Rekruttering
- University of Texas Health Science Center at Houston
-
Ledende efterforsker:
- Abhijeet Dhoble, MD
-
Kontakt:
- Matthew Franciskovich
-
Houston, Texas, Forenede Stater, 77030
- Rekruttering
- Baylor Saint Luke's (The Texas Heart Institute)
-
Kontakt:
- Sylvia Carranza
-
Ledende efterforsker:
- Guilerme Silva, MD
-
San Antonio, Texas, Forenede Stater, 78229
- Rekruttering
- Methodist Hospital
-
Kontakt:
- Abigail Eckenrode
-
Ledende efterforsker:
- Devang Patel, MD
-
-
Vermont
-
Burlington, Vermont, Forenede Stater, 05401
- Rekruttering
- University of Vermont Medical Center
-
Kontakt:
- Amy Henderson
-
Ledende efterforsker:
- Harold Dauerman, MD
-
-
Virginia
-
Charlottesville, Virginia, Forenede Stater, 22908
- Rekruttering
- University of Virginia Medical Center
-
Ledende efterforsker:
- John Saxon, MD
-
Kontakt:
- Erin Orr
-
Falls Church, Virginia, Forenede Stater, 22042
- Rekruttering
- Inova Fairfax Hospital
-
Kontakt:
- Diana McLean
-
Ledende efterforsker:
- Matthew Sherwood, MD
-
Norfolk, Virginia, Forenede Stater, 23507
- Rekruttering
- Sentara Norfolk General Hospital
-
Ledende efterforsker:
- Matthew Summers, MD
-
Kontakt:
- Christine Calayo
-
Ledende efterforsker:
- Clinton Kemp, MD
-
-
Washington
-
Spokane, Washington, Forenede Stater, 99204
- Rekruttering
- Providence Heart Institute (Providence Sacred Heart)
-
Kontakt:
- Nicole McConnell
-
Ledende efterforsker:
- Brydan Curtis, MD
-
-
Wisconsin
-
Milwaukee, Wisconsin, Forenede Stater, 53226
- Rekruttering
- Froedtert Hospital
-
Ledende efterforsker:
- Saif Anwaruddin, MD
-
Kontakt:
- Amy Blair
-
Milwaukee, Wisconsin, Forenede Stater, 53215
- Rekruttering
- Aurora St. Lukes Medical Center
-
Ledende efterforsker:
- Tanvir Bajwa, MD
-
Kontakt:
- Reva Matz
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
The study population includes patients with symptomatic heart disease due to BVF affecting TAVs and requiring redo TAVR.
Beskrivelse
Inclusion Criteria:
- BVF of a TAV (either Medtronic or Edwards) requiring redo TAVR
Exclusion Criteria:
- BVF due solely to paravalvular regurgitation
- Active endocarditis
- Untreated acute valve thrombosis
- Life-expectancy less than 1-year
- Subject is less than legal age of consent, legally incompetent, or otherwise vulnerable
- Participating in another study that may influence the outcome of this study
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: COHORT
- Tidsperspektiver: PROSPECTIVE
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
|---|---|
|
Medtronic Transcatheter Aortic Valves (TAV) or Edwards Transcatheter Aortic Valves (TAV)
Subjects will receive either a Medtronic TAV or Edwards TAV |
Medtronic TAV where commercially available Edwards TAV where commercially available. |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Primary Outcome Measure
Tidsramme: Early (30-days)
|
30-day redo TAVR success defined as correct positioning of a single redo prosthetic heart valve into the proper anatomic location, intended performance of the valve (mean gradient <20mmHg, peak velocity <3 m/s, Doppler velocity index (DVI) ≥0.25, aortic regurgitation (AR) < moderate), and freedom from all-cause mortality, coronary obstruction, unplanned coronary revascularization, and surgery or intervention related to the device |
Early (30-days)
|
|
Primary Outcome Measure
Tidsramme: Late (1-year)
|
a composite endpoint of 1-year freedom from all-cause mortality, all stroke, or any re-hospitalization for valve or redo TAVR procedure-related causes |
Late (1-year)
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Valve Academic Research Consortium (VARC) 3 technical success (at exit from procedure room)
Tidsramme: Time of procedure
|
(VARC) 3 technical success (at exit from procedure room) |
Time of procedure
|
|
VARC 3 30-day device success
Tidsramme: 30-Day
|
30-day device success |
30-Day
|
|
VARC 3 30-day early safety
Tidsramme: 30-Day
|
30-day early safety |
30-Day
|
|
Peak and mean invasive gradient post-procedure
Tidsramme: Time of procedure
|
Peak and mean invasive gradient will be measured in mmHg |
Time of procedure
|
|
In-hospital clinical outcomes
Tidsramme: Treatment up to 7 days (or until patient is discharged from the hospital if later than 7 days)
|
Percentage of all participants with all-cause mortality, all stroke, Myocardial infarction (MI), Coronary artery obstruction, Unplanned Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Grafting (CABG), Bleeding (VARC 3 type 1-4), Major and Minor vascular and access-related complications, Cardiac structural complications, Permanent pacemaker implantation (PPI), Acute Kidney Injury (AKI) stage 1-4, Endocarditis, and Valve Thrombosis. |
Treatment up to 7 days (or until patient is discharged from the hospital if later than 7 days)
|
|
Clinical outcomes at 30 days, 1-year, and annually thereafter
Tidsramme: 30 days, at 1 year, at 2 years, at 3 years, at 4 years, and at 5 years.
|
All-cause mortality, All stroke, Myocardial infarction (MI), Coronary artery obstruction, Bleeding (VARC 3 type 1-4), Major and Minor vascular and access-related complications, Cardiac structural complications, Permanent pacemaker implantation (PPI), Acute Kidney Injury (AKI) stage 1-4, Endocarditis, Valve Thrombosis, Any rehospitalization and re-intervention. |
30 days, at 1 year, at 2 years, at 3 years, at 4 years, and at 5 years.
|
|
Bioprosthetic Valve Dysfunction (BVD) at the final required follow-up visit
Tidsramme: 5 year
|
Intrinsic permanent changes to the prosthetic valve, including wear and tear, leaflet disruption, flail leaflet, leaflet fibrosis and/or calcification, or strut fracture or deformation |
5 year
|
|
Bioprosthetic Valve Failure (BVF) at the final required follow-up visit
Tidsramme: Through study completion or Up to 5-years
|
Any bioprosthetic valve dysfunction associated with clinically expressive criteria (new-onset or worsening symptoms, left ventricle dilation/hypertrophy/dysfunction, or pulmonary hypertension) or irreversible Stage 3 Hemodynamic Valve Deterioration (HVD) or Aortic valve reoperation or re-intervention, or Valve-related death. |
Through study completion or Up to 5-years
|
|
Echocardiographic assessment pre-discharge or at 30 days, 1-year, and annually thereafter
Tidsramme: After the procedure and prior to discharge from the hospital, at 30 days, at 1 year, at 2 years, at 3 years, at 4 years, and at 5 years.
|
Left ventricular ejection fraction, mean gradient across aortic valve, effective orifice area, effective orifice area index, patient-prosthesis mismatch, Doppler Velocity Index, total aortic regurgitation, paravalvular aortic regurgitation, and transvalvular aortic regurgitation. |
After the procedure and prior to discharge from the hospital, at 30 days, at 1 year, at 2 years, at 3 years, at 4 years, and at 5 years.
|
|
Evaluate coronary accessibility (e.g., commissural alignment, valve to valve alignment, etc.) based on Computed Tomography (CT) at either pre-discharge or 30 days
Tidsramme: Up to 30 days
|
Evaluate coronary accessibility |
Up to 30 days
|
|
New York Heart Association (NYHA) classification at pre-discharge, 30 days, 1-year, and annually thereafter
Tidsramme: After the procedure and prior to discharge from the hospital, at 30 days, at 1 year, at 2 years, at 3 years, at 4 years, and at 5 years.
|
New York Heart Association (NYHA) classification |
After the procedure and prior to discharge from the hospital, at 30 days, at 1 year, at 2 years, at 3 years, at 4 years, and at 5 years.
|
|
KCCQ Quality of life (QoL) assessments at 30 days, 1-year, and annually thereafter
Tidsramme: At 30 days, at 1 year, at 2 years, at 3 years, at 4 years, and at 5 years.
|
QoL: KCCQ assessment |
At 30 days, at 1 year, at 2 years, at 3 years, at 4 years, and at 5 years.
|
|
EQ5D Quality of life (QoL) assessments at 30 days, 1-year, and annually thereafter
Tidsramme: At 30 days, at 1 year, at 2 years, at 3 years, at 4 years, and at 5 years.
|
QoL: EQ5D assessment |
At 30 days, at 1 year, at 2 years, at 3 years, at 4 years, and at 5 years.
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Guilherme Attizzani, MD, UH, Cleveland Medical Center
- Studiestol: Gregory Fontana, MD, Los Robles Regional Medical Center
- Ledende efterforsker: Basel Ramlawi, Lankenau Heart Institute
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- MDT23040EVR015
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
produkt fremstillet i og eksporteret fra U.S.A.
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .